HCW Biologics Inc (HCWB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.73M
Last updated: Nov 17, 2026 at 10:58 AM ET
HCW Biologics Inc (HCWB) Earnings: Report Dates and Results
In the quarter ended Jun 30, 2026, HCW Biologics reported EPS of -$10.10, below the -$1.98 estimate. It beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
HCWB's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.
Earnings History
Of the 18 quarters below that had an estimate, HCWB beat 6, missed 11 and matched 1. Revenue for the quarter ended Jun 30, 2026 was $135568, up 1969.7% from $6550 a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | -$10.10 | -$1.98 | -$1.98 - -$1.98 | -410.10% | Miss | N/A | 1 | 0 up, 1 down | Aug 14, 2026 | $135568 |
| Mar 31, 2026 | $2.22 | -$2.64 | -$2.64 - -$2.64 | +184.09% | Beat | N/A | 1 | 1 up, 0 down | May 14, 2026 | $6.54M |
| Dec 31, 2025 | -$6.12 | -$5.04 | N/A | -21.43% | Miss | N/A | 1 | 1 up, 0 down | Mar 31, 2026 | $27011 |
| Sep 30, 2025 | -$12.12 | $9.48 | $9.48 - $9.48 | -227.85% | Miss | N/A | 1 | 1 up, 0 down | Nov 14, 2025 | $15606 |
| Jun 30, 2025 | -$6.79 | $10.80 | N/A | -162.87% | Miss | N/A | N/A | 0 up, 0 down | Aug 18, 2025 | $6550 |
| Mar 31, 2025 | -$0.05 | N/A | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | May 15, 2025 | $5065 |
| Dec 31, 2024 | -$19.20 | $21.60 | N/A | -188.89% | Miss | N/A | N/A | N/A | Mar 28, 2025 | $394803 |
| Sep 30, 2024 | -$24.00 | -$31.20 | N/A | +23.08% | Beat | N/A | N/A | N/A | Nov 14, 2024 | $426423 |
| Jun 30, 2024 | -$96.00 | -$43.20 | N/A | -122.22% | Miss | N/A | N/A | 0 up, 0 down | Aug 14, 2024 | $618854 |
| Mar 31, 2024 | -$72.00 | -$36.00 | N/A | -100.00% | Miss | N/A | N/A | 0 up, 0 down | May 15, 2024 | $1.13M |
| Dec 31, 2023 | -$0.30 | -$0.15 | N/A | -106.90% | Miss | N/A | 1 | 0 up, 0 down | Mar 26, 2024 | $1.32M |
| Sep 30, 2023 | -$33.60 | -$31.20 | N/A | -7.69% | Miss | N/A | 2 | 0 up, 0 down | Nov 14, 2023 | $853102 |
| Jun 30, 2023 | -$28.80 | -$37.20 | -$38.39 - -$33.59 | +22.58% | Beat | N/A | 3 | 0 up, 0 down | Aug 11, 2023 | $622807 |
| Mar 31, 2023 | -$0.14 | -$0.14 | -$0.16 - -$0.12 | 0.00% | In line | N/A | 2 | 0 up, 0 down | May 9, 2023 | $41883 |
| Dec 31, 2022 | -$36.00 | -$34.80 | N/A | -3.45% | Miss | N/A | 2 | 0 up, 0 down | Mar 28, 2023 | $1.34M |
| Sep 30, 2022 | -$26.40 | -$31.20 | N/A | +15.38% | Beat | N/A | 1 | 0 up, 0 down | Nov 7, 2022 | $1.81M |
| Jun 30, 2022 | -$24.00 | -$30.00 | -$33.59 - -$26.39 | +20.00% | Beat | N/A | 2 | 0 up, 0 down | Aug 12, 2022 | $454000 |
| Mar 31, 2022 | -$14.40 | -$33.60 | N/A | +57.14% | Beat | N/A | 1 | 0 up, 0 down | May 13, 2022 | $3.12M |
| Dec 31, 2021 | -$0.17 | -$0.12 | -$0.12 - -$0.12 | -41.67% | Miss | N/A | 2 | 0 up, 0 down | Mar 29, 2022 | N/A |
| Sep 30, 2021 | -$0.08 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 12, 2021 | N/A |
| Jun 30, 2021 | -$0.20 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 13, 2021 | N/A |
| Mar 31, 2021 | -$0.66 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 30, 2021 | N/A |
| Dec 31, 2020 | -$0.69 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2021 | $4.10M |
| Jun 30, 2020 | -$0.63 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 30, 2020 | N/A |
| Mar 31, 2020 | -$0.65 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 30, 2020 | N/A |
| Dec 31, 2019 | -$0.56 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2020 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$25.08, after -$211.20 the year before. It was -$0.56 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$25.08 | N/A |
| Dec 31, 2024 | -$211.20 | N/A |
| Dec 31, 2023 | -$62.84 | N/A |
| Dec 31, 2022 | -$100.80 | N/A |
| Dec 31, 2021 | -$1.11 | N/A |
| Dec 31, 2020 | -$1.96 | N/A |
| Dec 31, 2019 | -$0.56 | N/A |
Frequently Asked Questions About HCWB
Did HCWB beat earnings estimates last quarter?
No. HCW Biologics reported EPS of -$10.10 for the quarter ended Jun 30, 2026, below the -$1.98 estimate by 410.10%.
What EPS do analysts expect from HCWB next quarter?
The consensus EPS estimate for HCW Biologics for the quarter ending Dec 31, 2026 is -$1.42 from 3 analysts.
How often does HCWB beat earnings estimates?
HCW Biologics beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate, with an average surprise of -115.77%.
HCWB pages: Overview, Earnings, Forecast, Financials, Competitors